Free Trial

Biodesix (BDSX) Competitors

Biodesix logo
$0.28 +0.00 (+1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$0.28 +0.00 (+0.80%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BDSX vs. EUDA, NAKA, KDLY, QIPT, ATPC, OPGN, PIII, BNR, BMGL, and CCM

Should you be buying Biodesix stock or one of its competitors? The main competitors of Biodesix include EUDA Health (EUDA), KindlyMD (NAKA), Kindly MD (KDLY), Quipt Home Medical (QIPT), Agape ATP (ATPC), OpGen (OPGN), P3 Health Partners (PIII), Burning Rock Biotech (BNR), Basel Medical Group (BMGL), and Concord Medical Services (CCM). These companies are all part of the "healthcare" industry.

Biodesix vs. Its Competitors

Biodesix (NASDAQ:BDSX) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

EUDA Health has a net margin of 0.00% compared to Biodesix's net margin of -54.28%. EUDA Health's return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-54.28% -167.28% -39.96%
EUDA Health N/A N/A N/A

Biodesix currently has a consensus price target of $1.75, suggesting a potential upside of 534.52%. Given Biodesix's higher probable upside, research analysts plainly believe Biodesix is more favorable than EUDA Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Biodesix's average media sentiment score of 0.00 equaled EUDA Health'saverage media sentiment score.

Company Overall Sentiment
Biodesix Neutral
EUDA Health Neutral

EUDA Health has lower revenue, but higher earnings than Biodesix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$71.32M0.57-$42.93M-$0.29-0.95
EUDA Health$4.01M30.86-$15.36MN/AN/A

Biodesix has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500.

Summary

EUDA Health beats Biodesix on 7 of the 13 factors compared between the two stocks.

Get Biodesix News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDSX vs. The Competition

MetricBiodesixMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$39.81M$7.31B$5.53B$9.03B
Dividend YieldN/A2.78%5.24%4.01%
P/E Ratio-0.9518.5519.3119.89
Price / Sales0.5732.04424.59117.07
Price / CashN/A20.3926.2128.59
Price / Book1.976.687.925.55
Net Income-$42.93M$230.16M$3.17B$248.49M
7 Day Performance-2.27%1.48%2.18%5.37%
1 Month Performance-8.95%0.36%1.25%6.63%
1 Year Performance-82.43%37.58%33.90%21.20%

Biodesix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDSX
Biodesix
3.3689 of 5 stars
$0.28
+1.5%
$1.75
+534.5%
-82.4%$39.81M$71.32M-0.95220
EUDA
EUDA Health
N/A$3.58
+4.4%
N/A-10.0%$127.45M$4.01M0.002Gap Up
NAKA
KindlyMD
N/A$13.85
-3.0%
N/AN/A$86.10M$2.72M0.00N/APositive News
Gap Down
KDLY
Kindly MD
N/A$14.28
-2.7%
N/A+466.7%$85.99M$2.47M-18.55N/APositive News
QIPT
Quipt Home Medical
2.9151 of 5 stars
$1.79
-0.6%
$2.85
+59.2%
-40.7%$78.20M$245.91M0.001,200News Coverage
ATPC
Agape ATP
N/A$1.32
flat
N/A-66.5%$66.01M$1.32M0.0040Gap Down
OPGN
OpGen
N/A$4.78
+1.7%
N/A+77.2%$48.13M$2.67M0.00100Gap Down
PIII
P3 Health Partners
2.8983 of 5 stars
$6.30
-1.1%
$16.25
+157.9%
-74.5%$45.79M$1.50B0.00500Positive News
BNR
Burning Rock Biotech
N/A$3.17
+3.6%
N/A-44.7%$32.93M$70.67M0.001,390Gap Down
BMGL
Basel Medical Group
N/A$1.78
+1.7%
N/AN/A$32.30MN/A0.0036
CCM
Concord Medical Services
0.8405 of 5 stars
$5.73
+4.0%
N/A-43.3%$23.92M$52.60M0.00970News Coverage

Related Companies and Tools


This page (NASDAQ:BDSX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners